Capvizr
THE DEAL, AT A GLANCE

Evvy

2/4 explanations supported
Evvy source image associated with the reported financing
Evvy

Evvy sells at-home vaginal microbiome tests with clinician-reviewed results and care plans.

Source-provided image · View source ↗
01What it doesEvvy sells at-home vaginal microbiome tests with clinician-reviewed results and care plans.Source-grounded · automated review · Explore ↗

Checked 2026-09-15 · Review due 2026-09-22

Read supporting source ↗
Our at-home vaginal microbiome test…
02Who is involvedEvidence still neededOpen review status ↗

The supplied document names no Series B investors, previous-round investors, lenders, arrangers, or financing participants. Treating investor information as missing is supported. No investor or role claims should be added from this evidence.

03What happenedEvidence still neededOpen review status ↗

The supplied document does not establish a Series B financing event, announcement date, amount, currency, valuation, round terms, closing, or completion status. The target Series B dated 2026-09-15 is not supported by the provided document, so eventMatch is false.

04Why it mattersIt turns one home swab into clinician-reviewed vaginal health guidance and possible prescriptions.Interpretation · Explore ↗

Checked 2026-09-15 · Review due 2026-09-22

Read supporting source ↗
Your results are reviewed by…
Click a part to explore its evidence. The image is supplied by the cited source.Original record source ↗

Evvy · Financing Record

Explore source-linked visual explanations for Evvy. Unsupported claims are withheld while source review continues.

Record 12341 · Recorded date: 2026-09-15

Open record 12341 →

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime